Almarzoky Abuhussain, Safa S.
Burak, Michelle A.
Kohman, Kelsey N.
Jacknin, Gabrielle
Tart, Serina B.
Hobbs, Athena L. V.
Adams, Danyel K.
Nailor, Michael D.
Keyloun, Katelyn R.
Nicolau, David P.
Kuti, Joseph L.
Funding for this research was provided by:
Allergan plc, Jersey City, NJ
Article History
Received: 6 June 2018
Accepted: 21 November 2018
First Online: 4 December 2018
Ethics approval and consent to participate
: This study was approved by the Hartford Healthcare Institutional Review Board (Hartford, CT), Cape Fear Valley Health System IRB (Fayetteville, NC), Baylor Scott & White Research Institute IRB (Dallas, TX), University of Colorado Health IRB (Aurora, CO), BMHCC Institutional Review Board (Memphis, TN), and Baystate Medical Center Institutional Review Board (Springfield, MA). Written informed consent was obtained from each participant.
: Not applicable.
: KRK is a full-time employee of Allergan plc and may hold stock or stock options. JLK serves as an advisor and is a member of the speakers’ bureau for Allergan plc. The other authors have nothing to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.